Page last updated: 2024-08-18

quinuclidines and piplartine

quinuclidines has been researched along with piplartine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hang, W; Jian, YP; Li, DD; Li, YL; Liu, G; Quan, CS; Shen, XF; Sun, QH; Wang, YS; Xu, ZX; Yin, ZX; Zeng, Q; Zhang, YH; Zhao, RX	1

Other Studies

1 other study(ies) available for quinuclidines and piplartine

Article	Year
Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1. Oncogene, 2018, Volume: 37, Issue:25 Topics: Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cell Proliferation; Dioxolanes; Drug Therapy, Combination; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Head and Neck Neoplasms; Humans; Male; Mice; Mice, SCID; Prognosis; Quinuclidines; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2018

Article

Year

Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1.

Oncogene, 2018, Volume: 37, Issue:25

Topics: Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cell Proliferation; Dioxolanes; Drug Therapy, Combination; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Head and Neck Neoplasms; Humans; Male; Mice; Mice, SCID; Prognosis; Quinuclidines; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2018